A detailed history of Atria Investments LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Atria Investments LLC holds 21,968 shares of PACB stock, worth $43,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,968
Previous 11,830 85.7%
Holding current value
$43,276
Previous $16,000 131.25%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$1.2 - $2.17 $12,165 - $21,999
10,138 Added 85.7%
21,968 $37,000
Q2 2024

Aug 13, 2024

BUY
$1.36 - $3.65 $16,088 - $43,179
11,830 New
11,830 $16,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $443M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.